What is MRK's current stock price?

As of now, MRK is trading at $99.68, with a daily change of +0.70%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

MRK Stock Analysis & IQ Rating | Merck Company

MRK

Merck Company

$99.68

+$0.67 | +0.70%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$105.84

MKT CAP

$247.51B

52W Low

$73.31

VOL

$6.20M

P/E Ratio

13.19

AVG VOL

$14.89M

RSI

58.77

TREND

Uptrend

MRK Stock IQ

Login to see Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRK Target Price

Login to display

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Trading below its fair value

Risk Analysis

MRK Risk Analysis

Investors losing their confidence

MRK Price Performance

$92.92 (+7.28%)

$81.6 (+22.16%)

$83.98 (+18.69%)

$99.87 (-0.19%)

1year

6month

3month

1month

MRK Risk Level

MRK has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

MRK Analysts Opinion

MRK overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

MRK Analysts Opinion

MRK Analysts opinion is positive and also has improved from the past 3 months

MRK Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

73%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

70%

37%

MRK Street Sentiment

MRK Street Sentiment is bullish and have positive views on the near-term outlook

MRK Performance Sentiment

Sentiments overview associated with MRK events and the stock performance.

73%

6%

Positive

Negative

45 out of 62
events present

4 out of 62
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$98.93

Resistance
Price

$86.75

Current Price Range

$105.66

Show methods +

Linked to MRK

IQ

Close Price

Change

AZN

4.31

89.65

-0.71%

PFE

3.94

25.81

-0.04%

NVS

4.27

132.25

-0.08%

SNY

4.02

48.73

-0.27%

ABBV

4.12

221.67

-1.03%

MRK Latest Analysis +

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Today

$99.68 | +0.70%

Potential

Can MRKs New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?. Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytrudas 2028 LOE nears.

Today

$99.68 | +0.70%

Activity

Potential

Merck (MRK) Laps the Stock Market: Heres Why. Merck (MRK) closed at $99.01 in the latest trading session marking a 1.42% move from the prior day.

Thu Dec 11, 2025

$99.01 | +1.42%

Momentum

Ex-Dividend Reminder: Gilead Sciences Merck and Horace Mann Educators. Looking at the universe of stocks we cover at Dividend Channel on 12/15/25 Gilead Sciences Inc (Symbol: GILD) Merck &. Co Inc (Symbol: MRK) and Horace Mann Educators Corp. (Symbol: HMN) will all trade ex-dividend for their respective upcoming dividends. Gilead Sciences In

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Oruka Therapeutics Announces New Board Member and Board Transition. MENLO PARK Calif. Dec. 11 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics Inc. (Oruka) (NASDAQ:) a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO) today announced the appointment of Chris Martin to its Board of Directors. Additionally Cameron Turtle DPhil resigned from the Board effective December 11 2025.As we

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Guru Fundamental Report for MRK - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Thu Dec 11, 2025

$99.01 | +1.42%

Potential

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™. Delray Beach FL Dec. 11 2025 (GLOBE NEWSWIRE) -- Emerging markets breakthrough technologies and strategic M&.A reshape competitive landscapeThe global is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in 2025 at a CAGR of 7.1% from 2025 to 2030. The surge is attributed to rapidly increasing global cancer rates growing genetic disorder prevalence and the expanding adoption of ad

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Merck & Co. (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1.

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Immutep Limited (IMMP): Firm Reports Positive Data from Trials. Immutep Limited (NASDAQ:IMMP) is one of the Best Micro-Cap Stocks to Invest in According to Analysts. In mid-November Immutep Limited (NASDAQ:IMMP) reported positive data from two clinical trials of its drug candidate eftilagimod alpha or efti. The firm revealed that a Phase 2 study of efti in combination with radiotherapy and Mercks Keytruda showed significant [….]

Wed Dec 10, 2025

$97.62 | +0.75%

Potential

MRK Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Wed Dec 10, 2025

$97.62 | +0.75%

Potential

FAQ About MRK Stock Insights

What is MRK current stock price?

What are MRK stock strengths?

What is MRK Risk Level?

What is MRK market cap and volume?

What is MRK current Stock IQ?

Should I buy MRK stock right now?

Is MRK a Strong Buy right now?

What does a 'Strong Buy' rating mean for MRK?

What does a 'Strong Sell' rating mean for MRK?

What factors influence MRK's Stock IQ?

Explore our MRK Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored MRK Stock Strategies
Effective Risk Management

FIND US ON

Receive our MRK Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

MRK

Merck Company

Current Price

$99.68

+$0.67 | +0.70%

52W High

$105.84

MKT CAP

$247.51B

52W Low

$73.31

VOL

$6.20M

P/E Ratio

13.19

AVG VOL

$14.89M

RSI

58.77

TREND

Uptrend

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

MRK Rewards

Earnings are forecast to grow

MRK Rewards

Trading below its fair value

Risk Analysis

MRK Risk Analysis

Investors losing their confidence

Linked to MRK

Symbol

IQ

Close

Change

AZN

4.31

89.65

-0.71%

PFE

3.94

25.81

-0.04%

NVS

4.27

132.25

-0.08%

SNY

4.02

48.73

-0.27%

ABBV

4.12

221.67

-1.03%

MRK Price Performance

$92.92 (+7.28%)

$81.6 (+22.16%)

$83.98 (+18.69%)

$99.87 (-0.19%)

1year

6month

3month

1month

MRK Analysts Opinion

MRK Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

MRK Analysts Opinion

MRK Analysts opinion is positive and also has improved from the past 3 months

MRK Street Sentiment

Analysts perspectives on the stock desirability, trend direction, and growth potential

73%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

80%

70%

37%

MRK Street Sentiment

MRK Street Sentiment is bullish and have positive views on the near-term outlook

MRK Risk Level

MRK has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

MRK Performance Sentiment

Sentiments overview associated with MRK events and the stock performance.

73%

6%

Positive

Negative

45 out of 62
events present

4 out of 62
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Login to display

Support
Price

$98.93

Resistance
Price

$86.75

Current Price Range

$105.66

Show methods +

MRK Stock IQ

Login to unlock Merck Company (MRK) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

MRK Latest Analysis

Peter Lynch Detailed Fundamental Analysis - MRK. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Today

$99.68 | +0.70%

Potential

Can MRKs New Drugs & Pipeline Help Navigate the Looming Keytruda LOE?. Merck leans on a fast-growing pipeline and new product launches to aid long-term growth as Keytrudas 2028 LOE nears.

Today

$99.68 | +0.70%

Activity

Potential

Merck (MRK) Laps the Stock Market: Heres Why. Merck (MRK) closed at $99.01 in the latest trading session marking a 1.42% move from the prior day.

Thu Dec 11, 2025

$99.01 | +1.42%

Momentum

Ex-Dividend Reminder: Gilead Sciences Merck and Horace Mann Educators. Looking at the universe of stocks we cover at Dividend Channel on 12/15/25 Gilead Sciences Inc (Symbol: GILD) Merck &. Co Inc (Symbol: MRK) and Horace Mann Educators Corp. (Symbol: HMN) will all trade ex-dividend for their respective upcoming dividends. Gilead Sciences In

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Oruka Therapeutics Announces New Board Member and Board Transition. MENLO PARK Calif. Dec. 11 2025 (GLOBE NEWSWIRE) -- Oruka Therapeutics Inc. (Oruka) (NASDAQ:) a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis (PsO) today announced the appointment of Chris Martin to its Board of Directors. Additionally Cameron Turtle DPhil resigned from the Board effective December 11 2025.As we

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Guru Fundamental Report for MRK - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Thu Dec 11, 2025

$99.01 | +1.42%

Potential

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™. Delray Beach FL Dec. 11 2025 (GLOBE NEWSWIRE) -- Emerging markets breakthrough technologies and strategic M&.A reshape competitive landscapeThe global is projected to reach USD 1.43 billion by 2030 from USD 1.02 billion in 2025 at a CAGR of 7.1% from 2025 to 2030. The surge is attributed to rapidly increasing global cancer rates growing genetic disorder prevalence and the expanding adoption of ad

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Merck & Co. (MRK) Gets Conditional Approval For EXZOLT CATTLE-CA1.

Thu Dec 11, 2025

$99.01 | +1.42%

Activity

Immutep Limited (IMMP): Firm Reports Positive Data from Trials. Immutep Limited (NASDAQ:IMMP) is one of the Best Micro-Cap Stocks to Invest in According to Analysts. In mid-November Immutep Limited (NASDAQ:IMMP) reported positive data from two clinical trials of its drug candidate eftilagimod alpha or efti. The firm revealed that a Phase 2 study of efti in combination with radiotherapy and Mercks Keytruda showed significant [….]

Wed Dec 10, 2025

$97.62 | +0.75%

Potential

MRK Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for MERCK &. CO INC (MRK). Of the 22 guru strategies we follow MRK rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relati

Wed Dec 10, 2025

$97.62 | +0.75%

Potential

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRK. We're here to help you make informed investment decisions today.

FIND US ON

Receive our MRK Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

MRK Stock trends

MRK Stock performance

MRK Stock analysis

MRK investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing MRK

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

MRK Stock Analysis & IQ Rating | Merck Company

MRK Stock IQ

MRK Target Price

MRK Risk Level

MRK Analysts Opinion

MRK Street Sentiment

MRK Performance Sentiment

Technical Price Levels

Explore our MRK Stock insights

Receive our MRK Daily Alerts

MRK Street Sentiment

MRK Risk Level

Technical Price Levels

Discover MRK Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of MRK. We're here to help you make informed investment decisions today.

Receive our MRK Daily Alerts

MRK Runner Alarm